Medtronic (MDT) Expands AI-Driven Care With New Partnership
https://www.zacks.com/stock/news/2197563/medtronic-mdt-expands-ai-driven-care-with-new-partnership?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2197563
Dec 13, 2023 - Medtronic's (MDT) expanded collaboration with Cosmo Pharmaceuticals is a strategic step forward in its quest to use AI to improve patient care.
0
Here's Why You Should Retain Exact Sciences (EXAS) Stock Now
https://www.zacks.com/stock/news/2197564/here-s-why-you-should-retain-exact-sciences-exas-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197564
Dec 13, 2023 - Investors are optimistic about Exact Sciences (EXAS) on strong Cologuard adoption and raised guidance.
0
QIAGEN's (QGEN) Strategic Alliances Aid Amid Macro Woes
https://www.zacks.com/stock/news/2197534/qiagen-s-qgen-strategic-alliances-aid-amid-macro-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2197534
Dec 13, 2023 - QIAGEN (QGEN) aims to expand the NGS platform by rapidly scaling up the new Enterprise Genomics Services.
0
Integer Holdings Corporation (ITGR) Hit a 52 Week High, Can the Run Continue?
https://www.zacks.com/stock/news/2197283/integer-holdings-corporation-itgr-hit-a-52-week-high-can-the-run-continue?cid=CS-ZC-FT-52_week_high-2197283
Dec 13, 2023 - Integer (ITGR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
0
Charles River (CRL) Expands 3D In Vitro Services Via New Deal
https://www.zacks.com/stock/news/2197217/charles-river-crl-expands-3d-in-vitro-services-via-new-deal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2197217
Dec 13, 2023 - Charles River (CRL) finalizes agreement with service-based biotechnology company, CELLphenomics.
0
Here's Why You Should Retain McKesson (MCK) Stock for Now
https://www.zacks.com/stock/news/2197165/here-s-why-you-should-retain-mckesson-mck-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2197165
Dec 13, 2023 - McKesson (MCK) continues to benefit from strategic partnerships and strength in the Distribution Solutions segment.
0
Masimo's (MASI) ORi Favored by Study for PaO2 Information
https://www.zacks.com/stock/news/2196904/masimo-s-masi-ori-favored-by-study-for-pao2-information?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196904
Dec 12, 2023 - Masimo's (MASI) latest study indicates that ORi can be a valuable tool to provide information on arterial oxygenation even during OLV.
0
Here's Why You Should Retain Surmodics (SRDX) Stock for Now
https://www.zacks.com/stock/news/2196894/here-s-why-you-should-retain-surmodics-srdx-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196894
Dec 12, 2023 - Surmodics' (SRDX) solid prospects in the thrombectomy business raise optimism about the stock.
0
Here's Why Investors Should Retain ResMed (RMD) Stock for Now
https://www.zacks.com/stock/news/2196711/here-s-why-investors-should-retain-resmed-rmd-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2196711
Dec 12, 2023 - Investors continue to be optimistic about ResMed (RMD) due to the sustained growth in the SaaS business.
0
Thermo Fisher (TMO) Launches New Solutions for Clinical Labs
https://www.zacks.com/stock/news/2196649/thermo-fisher-tmo-launches-new-solutions-for-clinical-labs?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2196649
Dec 12, 2023 - Thermo Fisher (TMO) introduces the KingFisher Apex Dx system and Applied Biosystems MagMAX Dx Isolation Kit to improve preanalytical workflows for clinical laboratories.
0